PUBLISHER: 360iResearch | PRODUCT CODE: 1599202
PUBLISHER: 360iResearch | PRODUCT CODE: 1599202
Vascular Injury Treatment Market by Injury (Aneurysm & Pseudoaneurysm, Arteriovenous Fistula, Contusion or Intimal Flap), Treatment (Bypass Graft, Extra Anatomic Bypass, Lateral Arteriorrhaphy or Venorrhaphy), End-User - Global Forecast 2025-2030
The Vascular Injury Treatment Market was valued at USD 21.51 billion in 2023, expected to reach USD 24.45 billion in 2024, and is projected to grow at a CAGR of 13.76%, to USD 53.04 billion by 2030.
Vascular injury treatment encompasses a range of medical interventions designed to manage and repair damage to blood vessels, which can occur due to trauma, surgical complications, or certain medical conditions. Its necessity is driven by the critical role that blood vessels play in the circulatory system, supporting tissue viability and overall bodily function. Applications include emergency trauma care, vascular surgical procedures, and reconstructive techniques. End-use sectors primarily involve hospitals, trauma centers, and specialized surgical units.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2023] | USD 21.51 billion |
| Estimated Year [2024] | USD 24.45 billion |
| Forecast Year [2030] | USD 53.04 billion |
| CAGR (%) | 13.76% |
Market growth for vascular injury treatment is influenced by factors such as the increasing incidence of traumatic injuries, rising prevalence of vascular diseases like aneurysms and thrombosis, and advancements in medical technology. Additionally, an aging global population further intensifies demand, as older individuals are more susceptible to vascular complications. The surge in minimally invasive techniques, such as endovascular surgery, represents a significant opportunity, offering faster recovery times and reduced surgical risks. Companies can capitalize on these advancements by investing in developing cutting-edge devices and expanding partnerships with healthcare providers.
However, the market faces limitations and challenges, including the high cost of advanced vascular procedures and devices, regulatory hurdles, and the need for skilled practitioners to perform complex interventions. Furthermore, disparities in healthcare accessibility across different regions can affect market growth.
Innovation opportunities lie in enhancing imaging technologies for better diagnosis and precision in treatment plans, developing biodegradable stents, and exploring stem cell therapy for vascular regeneration. Research into materials science can also contribute to the creation of more durable and biocompatible vascular grafts. The market is characterized by robust competition, with key players investing heavily in research and development to differentiate their offerings. Businesses should focus on fostering interdisciplinary collaboration and improving healthcare infrastructure to streamline vascular injury treatment and facilitate wide-ranging market penetration.
Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Vascular Injury Treatment Market
The Vascular Injury Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.
- Market Drivers
- Rising incidence of vascular injury surgeries
- Rise in the occurrence of trauma due to the increase in the road accidents, cuts, violence
- Increasing number of collaborations by hospital to provide therapeutic solution for heart related diseases
- Market Restraints
- High cost associated with the vascular injury treatment
- Market Opportunities
- Growing medical tourism in developing countries
- Increasing advancement in technologies
- Market Challenges
- Side effects associated with vascular injury treatment
Porter's Five Forces: A Strategic Tool for Navigating the Vascular Injury Treatment Market
Porter's five forces framework is a critical tool for understanding the competitive landscape of the Vascular Injury Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.
PESTLE Analysis: Navigating External Influences in the Vascular Injury Treatment Market
External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Vascular Injury Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.
Market Share Analysis: Understanding the Competitive Landscape in the Vascular Injury Treatment Market
A detailed market share analysis in the Vascular Injury Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.
FPNV Positioning Matrix: Evaluating Vendors' Performance in the Vascular Injury Treatment Market
The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Vascular Injury Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.
Strategy Analysis & Recommendation: Charting a Path to Success in the Vascular Injury Treatment Market
A strategic analysis of the Vascular Injury Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.
Key Company Profiles
The report delves into recent significant developments in the Vascular Injury Treatment Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Aplagon Oy, Becton, Dickinson, and Company, Boston Scientific Corporation, Cardinal Health, Inc., Cardiva Medical, Inc., Cordis Corporation, Humacyte, Inc., Medtronic PLC, Mentice AB, Teleflex Incorporated, Terumo Corporation, Vasorum Ltd., Veryan Medical Ltd, and Vivasure Medical Ltd..
Market Segmentation & Coverage
This research report categorizes the Vascular Injury Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Based on Injury, market is studied across Aneurysm & Pseudoaneurysm, Arteriovenous Fistula, Contusion or Intimal Flap, Laceration or Transection, Spasm, and Thrombosis.
- Based on Treatment, market is studied across Bypass Graft, Extra Anatomic Bypass, Lateral Arteriorrhaphy or Venorrhaphy, Patch Angioplasty, and Thrombectomy.
- Based on End-User, market is studied across Ambulatory Surgical Center and Hospital.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
The report offers a comprehensive analysis of the market, covering key focus areas:
1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.
2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.
3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.
4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.
5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.
The report also answers critical questions to aid stakeholders in making informed decisions:
1. What is the current market size, and what is the forecasted growth?
2. Which products, segments, and regions offer the best investment opportunities?
3. What are the key technology trends and regulatory influences shaping the market?
4. How do leading vendors rank in terms of market share and competitive positioning?
5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rising incidence of vascular injury surgeries
- 5.1.1.2. Rise in the occurrence of trauma due to the increase in the road accidents, cuts, violence
- 5.1.1.3. Increasing number of collaborations by hospital to provide therapeutic solution for heart related diseases
- 5.1.2. Restraints
- 5.1.2.1. High cost associated with the vascular injury treatment
- 5.1.3. Opportunities
- 5.1.3.1. Growing medical tourism in developing countries
- 5.1.3.2. Increasing advancement in technologies
- 5.1.4. Challenges
- 5.1.4.1. Side effects associated with vascular injury treatment
- 5.1.1. Drivers
- 5.2. Market Segmentation Analysis
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
- 5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental
6. Vascular Injury Treatment Market, by Injury
- 6.1. Introduction
- 6.2. Aneurysm & Pseudoaneurysm
- 6.3. Arteriovenous Fistula
- 6.4. Contusion or Intimal Flap
- 6.5. Laceration or Transection
- 6.6. Spasm
- 6.7. Thrombosis
7. Vascular Injury Treatment Market, by Treatment
- 7.1. Introduction
- 7.2. Bypass Graft
- 7.3. Extra Anatomic Bypass
- 7.4. Lateral Arteriorrhaphy or Venorrhaphy
- 7.5. Patch Angioplasty
- 7.6. Thrombectomy
8. Vascular Injury Treatment Market, by End-User
- 8.1. Introduction
- 8.2. Ambulatory Surgical Center
- 8.3. Hospital
9. Americas Vascular Injury Treatment Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
10. Asia-Pacific Vascular Injury Treatment Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
11. Europe, Middle East & Africa Vascular Injury Treatment Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
12. Competitive Landscape
- 12.1. Market Share Analysis, 2023
- 12.2. FPNV Positioning Matrix, 2023
- 12.3. Competitive Scenario Analysis
- 12.4. Strategy Analysis & Recommendation
Companies Mentioned
- 1. 3M Company
- 2. Abbott Laboratories
- 3. Aplagon Oy
- 4. Becton, Dickinson, and Company
- 5. Boston Scientific Corporation
- 6. Cardinal Health, Inc.
- 7. Cardiva Medical, Inc.
- 8. Cordis Corporation
- 9. Humacyte, Inc.
- 10. Medtronic PLC
- 11. Mentice AB
- 12. Teleflex Incorporated
- 13. Terumo Corporation
- 14. Vasorum Ltd.
- 15. Veryan Medical Ltd
- 16. Vivasure Medical Ltd.
LIST OF FIGURES
- FIGURE 1. VASCULAR INJURY TREATMENT MARKET RESEARCH PROCESS
- FIGURE 2. VASCULAR INJURY TREATMENT MARKET SIZE, 2023 VS 2030
- FIGURE 3. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 5. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2023 VS 2030 (%)
- FIGURE 7. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 8. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
- FIGURE 9. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 10. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
- FIGURE 11. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 12. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 13. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 14. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 15. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 16. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 17. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 18. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 20. VASCULAR INJURY TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
- FIGURE 21. VASCULAR INJURY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
- TABLE 1. VASCULAR INJURY TREATMENT MARKET SEGMENTATION & COVERAGE
- TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
- TABLE 3. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
- TABLE 4. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 5. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 6. VASCULAR INJURY TREATMENT MARKET DYNAMICS
- TABLE 7. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
- TABLE 8. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY ANEURYSM & PSEUDOANEURYSM, BY REGION, 2018-2030 (USD MILLION)
- TABLE 9. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY ARTERIOVENOUS FISTULA, BY REGION, 2018-2030 (USD MILLION)
- TABLE 10. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY CONTUSION OR INTIMAL FLAP, BY REGION, 2018-2030 (USD MILLION)
- TABLE 11. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY LACERATION OR TRANSECTION, BY REGION, 2018-2030 (USD MILLION)
- TABLE 12. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY SPASM, BY REGION, 2018-2030 (USD MILLION)
- TABLE 13. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOSIS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 14. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 15. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY BYPASS GRAFT, BY REGION, 2018-2030 (USD MILLION)
- TABLE 16. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY EXTRA ANATOMIC BYPASS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 17. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY LATERAL ARTERIORRHAPHY OR VENORRHAPHY, BY REGION, 2018-2030 (USD MILLION)
- TABLE 18. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY PATCH ANGIOPLASTY, BY REGION, 2018-2030 (USD MILLION)
- TABLE 19. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBECTOMY, BY REGION, 2018-2030 (USD MILLION)
- TABLE 20. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 21. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2030 (USD MILLION)
- TABLE 22. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
- TABLE 23. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
- TABLE 24. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 25. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 26. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 27. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
- TABLE 28. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 29. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 30. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
- TABLE 31. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 32. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 33. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
- TABLE 34. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 35. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 36. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
- TABLE 37. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 38. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 39. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
- TABLE 40. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 41. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 42. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
- TABLE 43. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
- TABLE 44. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 45. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 46. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 47. AUSTRALIA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
- TABLE 48. AUSTRALIA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 49. AUSTRALIA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 50. CHINA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
- TABLE 51. CHINA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 52. CHINA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 53. INDIA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
- TABLE 54. INDIA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 55. INDIA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 56. INDONESIA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
- TABLE 57. INDONESIA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 58. INDONESIA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 59. JAPAN VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
- TABLE 60. JAPAN VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 61. JAPAN VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 62. MALAYSIA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
- TABLE 63. MALAYSIA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 64. MALAYSIA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 65. PHILIPPINES VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
- TABLE 66. PHILIPPINES VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 67. PHILIPPINES VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 68. SINGAPORE VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
- TABLE 69. SINGAPORE VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 70. SINGAPORE VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 71. SOUTH KOREA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
- TABLE 72. SOUTH KOREA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 73. SOUTH KOREA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 74. TAIWAN VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
- TABLE 75. TAIWAN VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 76. TAIWAN VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 77. THAILAND VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
- TABLE 78. THAILAND VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 79. THAILAND VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 80. VIETNAM VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
- TABLE 81. VIETNAM VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 82. VIETNAM VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 83. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
- TABLE 84. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 85. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 86. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 87. DENMARK VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
- TABLE 88. DENMARK VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 89. DENMARK VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 90. EGYPT VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
- TABLE 91. EGYPT VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 92. EGYPT VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 93. FINLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
- TABLE 94. FINLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 95. FINLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 96. FRANCE VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
- TABLE 97. FRANCE VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 98. FRANCE VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 99. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
- TABLE 100. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 101. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 102. ISRAEL VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
- TABLE 103. ISRAEL VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 104. ISRAEL VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 105. ITALY VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
- TABLE 106. ITALY VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 107. ITALY VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 108. NETHERLANDS VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
- TABLE 109. NETHERLANDS VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 110. NETHERLANDS VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 111. NIGERIA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
- TABLE 112. NIGERIA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 113. NIGERIA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 114. NORWAY VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
- TABLE 115. NORWAY VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 116. NORWAY VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 117. POLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
- TABLE 118. POLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 119. POLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 120. QATAR VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
- TABLE 121. QATAR VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 122. QATAR VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 123. RUSSIA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
- TABLE 124. RUSSIA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 125. RUSSIA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 126. SAUDI ARABIA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
- TABLE 127. SAUDI ARABIA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 128. SAUDI ARABIA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 129. SOUTH AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
- TABLE 130. SOUTH AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 131. SOUTH AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 132. SPAIN VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
- TABLE 133. SPAIN VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 134. SPAIN VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 135. SWEDEN VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
- TABLE 136. SWEDEN VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 137. SWEDEN VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 138. SWITZERLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
- TABLE 139. SWITZERLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 140. SWITZERLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 141. TURKEY VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
- TABLE 142. TURKEY VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 143. TURKEY VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 144. UNITED ARAB EMIRATES VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
- TABLE 145. UNITED ARAB EMIRATES VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 146. UNITED ARAB EMIRATES VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 147. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
- TABLE 148. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 149. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 150. VASCULAR INJURY TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
- TABLE 151. VASCULAR INJURY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
